DingXin Gene
鼎新基因
DingXin Gene
Biotech/Healthcare
Dingxin Gene was co-founded by a team with over ten years of experience in biopharmaceutical R&D and commercialization. Starting from foundational gene therapy delivery technology platforms, the company uses AAV viral vectors and non-viral vectors to precisely address clinical pain points in…
Latest round: Series A Extension (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.